Holst; Jens Juul
Patent Applications and Registrations
Patent applications and USPTO patent grants for Holst; Jens Juul.The latest application filed is for "gip peptide analogues".
- Holst; Jens Juul - Hellerup DK
- Holst; Jens Juul - Holte DK
| Patent | Date |
|---|---|
| Gip Peptide Analogues App 20210340211 - Sparre-Ulrich; Alexander Hovard ; et al. | 2021-11-04 |
| GIP peptide analogues Grant 10,968,266 - Sparre-Ulrich , et al. April 6, 2 | 2021-04-06 |
| Peptide Dual Agonists Of Gipr And Glp2r App 20200392198 - Hartmann; Bolette ; et al. | 2020-12-17 |
| Peptide dual agonists of GIPR and GLP2R Grant 10,774,127 - Hartmann , et al. Sept | 2020-09-15 |
| Combination Therapy For Treatment Of Bone Disorders App 20200261543 - Hartmann; Bolette ; et al. | 2020-08-20 |
| Long-acting Gip Peptide Analogues App 20200087373 - Rosenkilde; Mette Marie ; et al. | 2020-03-19 |
| Peptide Dual Agonists Of Gipr And Glp2r App 20190389924 - Hartmann; Bolette ; et al. | 2019-12-26 |
| Gip Peptide Analogues App 20180258152 - Sparre-Ulrich; Alexander Hovard ; et al. | 2018-09-13 |
| Treatment Of Insulin Resistance And Obesity By Stimulating Glp-1 Release App 20120128770 - Hansen; Harald S. ; et al. | 2012-05-24 |
| Use of GLP-1 Peptides App 20110028391 - Holst; Jens Juul ; et al. | 2011-02-03 |
| Use of GLP-1 Peptides App 20100113363 - Holst; Jens Juul ; et al. | 2010-05-06 |
| Use of GLP-1 Peptides App 20090149387 - Holst; Jens Juul ; et al. | 2009-06-11 |
| Use of GLP-2 and related compounds for the treatment, prevention, diagnosis, and prognosis of bone-related disorders and calcium homeostasis related syndromes Grant 7,371,721 - Henriksen , et al. May 13, 2 | 2008-05-13 |
| Use of GLP-1 peptides App 20070161568 - Holst; Jens Juul ; et al. | 2007-07-12 |
| Use of GLP-2 and related compounds for the treatment, prevention, diagnosis, and prognosis of bone-related disorders and calcium homeostasis related syndromes App 20050282749 - Henriksen, Dennis Bang ; et al. | 2005-12-22 |
| Use of GLP-1 peptides App 20030232754 - Holst, Jens Juul ; et al. | 2003-12-18 |
| Use of a pharmaceutical composition comprising an appetite-suppressing peptide Grant 5,912,229 - Thim , et al. June 15, 1 | 1999-06-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 